NAPROXEN SODIUM TABLET

NAPROXEN SODIUM TABLET was reported 66487 times

NAPROXEN SODIUM TABLET is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 JOINT LAXITY 36 0.1192
1 THERAPEUTIC PRODUCT EFFECTIVE FOR UNAPPROVED INDICATION 26 0.0701
2 INAPPROPRIATE PRESCRIBING 41 0.0666
3 FOREIGN BODY TRAUMA 45 0.0615
4 INCORRECT DOSAGE ADMINISTERED 278 0.0568
5 FAILURE OF CHILD RESISTANT MECHANISM FOR PHARMACEUTICAL PRODUCT 20 0.0457
6 INCORRECT DRUG ADMINISTRATION DURATION 1272 0.0452
7 DEVICE INEFFECTIVE 47 0.0439
8 EXPIRED PRODUCT ADMINISTERED 1195 0.0359
9 POOR QUALITY DRUG ADMINISTERED 229 0.0353
10 FOREIGN BODY IN RESPIRATORY TRACT 44 0.0335
11 THERAPEUTIC RESPONSE UNEXPECTED 1458 0.0325
12 GASTROINTESTINAL ULCER HAEMORRHAGE 36 0.0320
13 OROPHARYNGEAL SWELLING 28 0.0284
14 GASTRIC ULCER HAEMORRHAGE 157 0.0283
15 BLOOD URINE 27 0.0280
16 STOMACH DISCOMFORT 144 0.0278
17 RED BLOOD CELL SEDIMENTATION RATE ABNORMAL 61 0.0265
18 ULCER HAEMORRHAGE 176 0.0260
19 OESOPHAGEAL SPASM 47 0.0255
20 ACCIDENTAL EXPOSURE TO PRODUCT BY CHILD 173 0.0254
21 PRODUCT COMMINGLING 26 0.0244
22 FOREIGN BODY 94 0.0235
23 EXTRA DOSE ADMINISTERED 937 0.0231
24 PRE-EXISTING CONDITION IMPROVED 132 0.0211
25 PRODUCT CLOSURE REMOVAL DIFFICULT 21 0.0206
26 PRODUCT USE ISSUE 3736 0.0199
27 PRODUCT COATING ISSUE 20 0.0196
28 OBSTRUCTIVE SLEEP APNOEA SYNDROME 28 0.0192
29 PRODUCT PHYSICAL CONSISTENCY ISSUE 105 0.0190
30 GASTRIC HAEMORRHAGE 210 0.0182
31 DRUG EFFECT DELAYED 80 0.0176
32 PRODUCT PACKAGE ASSOCIATED INJURY 39 0.0175
33 OESOPHAGEAL PAIN 67 0.0169
34 GASTRIC ULCER PERFORATION 21 0.0166
35 DRUG EFFECT INCOMPLETE 599 0.0165
36 INCORRECT PRODUCT ADMINISTRATION DURATION 355 0.0164
37 GASTROINTESTINAL ULCER 36 0.0162
38 GASTRIC ULCER 301 0.0158
39 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 457 0.0156
40 CATAPLEXY 20 0.0141
41 EPIGASTRIC DISCOMFORT 54 0.0138
42 TONGUE DISCOMFORT 52 0.0122
43 HAEMORRHAGIC ANAEMIA 53 0.0120
44 PATIENT DISSATISFACTION WITH TREATMENT 22 0.0114
45 REBOUND ACID HYPERSECRETION 34 0.0112
46 THERAPEUTIC RESPONSE CHANGED 71 0.0112
47 OCCULT BLOOD POSITIVE 22 0.0112
48 DUODENAL ULCER HAEMORRHAGE 32 0.0112
49 GASTRIC PERFORATION 30 0.0110
50 ULCER 173 0.0109
51 ACCIDENTAL EXPOSURE 45 0.0108
52 PRODUCT PACKAGING DIFFICULT TO OPEN 28 0.0107
53 THROMBOPHLEBITIS SUPERFICIAL 32 0.0106
54 ORAL DISCOMFORT 142 0.0102
55 PEPTIC ULCER 33 0.0099
56 FAECES DISCOLOURED 209 0.0096
57 PRODUCT PRESCRIBING ISSUE 206 0.0094
58 LYMPHOEDEMA 65 0.0094
59 C-REACTIVE PROTEIN ABNORMAL 60 0.0093
60 UPPER GASTROINTESTINAL HAEMORRHAGE 156 0.0093
61 THERAPEUTIC PRODUCT EFFECT DELAYED 42 0.0092
62 PRODUCT CONTAMINATION PHYSICAL 23 0.0090
63 DRUG SCREEN POSITIVE 70 0.0088
64 HYPERPARATHYROIDISM SECONDARY 22 0.0088
65 NEPHROGENIC ANAEMIA 40 0.0086
66 PRODUCT SIZE ISSUE 46 0.0086
67 PRODUCT PHYSICAL ISSUE 171 0.0085
68 GENERALISED ERYTHEMA 47 0.0083
69 GASTRIC DISORDER 282 0.0082
70 GASTRITIS EROSIVE 37 0.0079
71 SLEEP APNOEA SYNDROME 149 0.0078
72 OESOPHAGEAL ULCER 30 0.0078
73 MEDICATION ERROR 432 0.0078
74 PRURITUS GENERALISED 168 0.0078
75 HANGOVER 27 0.0077
76 SPINAL COLUMN STENOSIS 36 0.0076
77 INTERVERTEBRAL DISC DEGENERATION 70 0.0076
78 LIP SWELLING 251 0.0075
79 INCREASED TENDENCY TO BRUISE 69 0.0075
80 DRUG PRESCRIBING ERROR 144 0.0075
81 SEASONAL ALLERGY 106 0.0075
82 SINUS HEADACHE 44 0.0074
83 INTERNAL HAEMORRHAGE 84 0.0073
84 BLOOD URINE PRESENT 139 0.0073
85 FOREIGN BODY IN THROAT 23 0.0073
86 RENAL PAIN 77 0.0073
87 DRUG SCREEN FALSE POSITIVE 20 0.0072
88 LYME DISEASE 24 0.0072
89 DIVERTICULUM 51 0.0072
90 PRODUCT LABEL ISSUE 48 0.0071
91 PRODUCT USE COMPLAINT 111 0.0070
92 OEDEMA MOUTH 23 0.0070
93 DYSPEPSIA 685 0.0070
94 CHOLECYSTITIS CHRONIC 46 0.0069
95 PERONEAL NERVE PALSY 39 0.0069
96 SWELLING FACE 445 0.0068
97 MULTIPLE ALLERGIES 53 0.0068
98 PHARYNGEAL OEDEMA 104 0.0068
99 PRODUCT TASTE ABNORMAL 91 0.0067
100 MUSCLE STRAIN 58 0.0067
101 DIFFICULTY IN WALKING 23 0.0067
102 SNORING 25 0.0066
103 ABDOMINAL DISCOMFORT 1105 0.0066
104 POOR QUALITY PRODUCT ADMINISTERED 69 0.0065
105 RENAL DISORDER 303 0.0065
106 NERVE COMPRESSION 60 0.0065
107 THROAT IRRITATION 291 0.0065
108 THERAPEUTIC PRODUCT EFFECT VARIABLE 25 0.0064
109 SENSATION OF FOREIGN BODY 54 0.0064
110 DIVERTICULUM INTESTINAL 28 0.0064
111 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 347 0.0063
112 HAEMATOCHEZIA 347 0.0063
113 ABDOMINAL PAIN UPPER 1294 0.0063
114 RENAL INJURY 186 0.0063
115 MENISCUS INJURY 38 0.0062
116 DRUG INEFFECTIVE 8133 0.0062
117 SCIATICA 98 0.0061
118 SPINAL OSTEOARTHRITIS 54 0.0061
119 TRIGGER FINGER 25 0.0061
120 HIATUS HERNIA 79 0.0061
121 INTERVERTEBRAL DISC DISORDER 26 0.0061
122 PRODUCT LEAKAGE 34 0.0061
123 ARTHRITIS 472 0.0060
124 MUSCULOSKELETAL DISCOMFORT 103 0.0060
125 TONGUE DISCOLOURATION 26 0.0059
126 HAEMORRHAGIC DIATHESIS 21 0.0059
127 SENSITIVITY TO WEATHER CHANGE 31 0.0059
128 PRODUCT ADMINISTRATION INTERRUPTED 46 0.0059
129 FIBROMYALGIA 142 0.0058
130 FEELING JITTERY 111 0.0058
131 GROIN PAIN 51 0.0058
132 HAEMATEMESIS 147 0.0058
133 SWOLLEN TONGUE 181 0.0058
134 CHRONIC KIDNEY DISEASE 437 0.0057
135 TOOTHACHE 104 0.0057
136 CHOKING 111 0.0057
137 DUODENAL ULCER 40 0.0057
138 ENERGY INCREASED 33 0.0056
139 MOUTH SWELLING 32 0.0055
140 ROTATOR CUFF SYNDROME 71 0.0055
141 BODY HEIGHT DECREASED 59 0.0055
142 EYE SWELLING 205 0.0055
143 CARPAL TUNNEL SYNDROME 77 0.0055
144 PRODUCT PACKAGING ISSUE 52 0.0055
145 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 48 0.0054
146 INTENTIONAL PRODUCT MISUSE 475 0.0054
147 MUSCULOSKELETAL PAIN 283 0.0054
148 WHEELCHAIR USER 24 0.0054
149 RHINITIS ALLERGIC 24 0.0054
150 ANAPHYLACTIC SHOCK 139 0.0054
151 JOINT EFFUSION 37 0.0054
152 EXOSTOSIS 49 0.0054
153 TENDONITIS 83 0.0054
154 BACK DISORDER 87 0.0053
155 HYPERVENTILATION 31 0.0053
156 SPINAL STENOSIS 22 0.0053
157 THROAT TIGHTNESS 143 0.0053
158 RECTAL HAEMORRHAGE 227 0.0053
159 SYNOVITIS 95 0.0053
160 CYSTITIS 167 0.0052
161 INFUSION SITE SWELLING 33 0.0052
162 BENIGN PROSTATIC HYPERPLASIA 27 0.0052
163 FLANK PAIN 49 0.0052
164 GASTROINTESTINAL HAEMORRHAGE 436 0.0052
165 CARDIAC MURMUR 45 0.0052
166 NOCTURIA 63 0.0052
167 NASAL DISCOMFORT 41 0.0052
168 INITIAL INSOMNIA 53 0.0052
169 POOR QUALITY SLEEP 111 0.0052
170 LOWER GASTROINTESTINAL HAEMORRHAGE 38 0.0051
171 PARAESTHESIA ORAL 74 0.0051
172 LOCAL SWELLING 89 0.0051
173 PRODUCT COLOUR ISSUE 26 0.0051
174 NEURALGIA 123 0.0051
175 PARANASAL SINUS DISCOMFORT 19 0.0050
176 ONYCHOMYCOSIS 22 0.0050
177 WALKING AID USER 33 0.0050
178 URTICARIA 838 0.0050
179 TENDERNESS 52 0.0050
180 BLOOD PRESSURE INCREASED 760 0.0050
181 HYPERSENSITIVITY 922 0.0050
182 RASH VESICULAR 24 0.0050
183 SINUS CONGESTION 67 0.0050
184 LIGAMENT SPRAIN 49 0.0050
185 OESOPHAGEAL DISORDER 19 0.0049
186 INCORRECT DRUG ADMINISTRATION RATE 21 0.0049
187 POLYARTHRITIS 26 0.0049
188 MUSCULOSKELETAL CHEST PAIN 76 0.0049
189 OSTEOARTHRITIS 208 0.0049
190 MICTURITION URGENCY 56 0.0049
191 FAECES HARD 19 0.0049
192 SKIN ABRASION 23 0.0049
193 PSYCHOLOGICAL TRAUMA 42 0.0049
194 FEELING DRUNK 36 0.0048
195 GASTROOESOPHAGEAL REFLUX DISEASE 388 0.0048
196 CONTUSION 461 0.0048
197 BACK INJURY 52 0.0048
198 FEELING OF BODY TEMPERATURE CHANGE 28 0.0048
199 GINGIVAL PAIN 38 0.0048
200 BONE DISORDER 87 0.0048
201 JOINT RANGE OF MOTION DECREASED 64 0.0048
202 HYPERLIPIDAEMIA 57 0.0048
203 DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 34 0.0047
204 JOINT STIFFNESS 124 0.0047
205 TINNITUS 217 0.0047
206 NEPHROPATHY 44 0.0047
207 INTERVERTEBRAL DISC PROTRUSION 103 0.0047
208 HYPOAESTHESIA ORAL 71 0.0047
209 DYSMENORRHOEA 62 0.0047
210 URINARY TRACT DISORDER 21 0.0047
211 HEART RATE ABNORMAL 26 0.0047
212 NECK PAIN 260 0.0046
213 OROPHARYNGEAL DISCOMFORT 42 0.0046
214 NASAL DRYNESS 29 0.0046
215 ORAL PAIN 103 0.0046
216 SINUS DISORDER 91 0.0046
217 URINE ODOUR ABNORMAL 27 0.0046
218 DRUG EFFECT LESS THAN EXPECTED 68 0.0046
219 NERVE INJURY 51 0.0046
220 DECREASED INTEREST 27 0.0046
221 RASH MACULAR 160 0.0046
222 MUSCLE TIGHTNESS 74 0.0046
223 GLUCOSE TOLERANCE IMPAIRED 27 0.0046
224 RESTLESS LEGS SYNDROME 83 0.0046
225 JOINT INJURY 97 0.0045
226 ARTHROPATHY 252 0.0045
227 LIGAMENT RUPTURE 20 0.0045
228 BACK PAIN 1051 0.0045
229 GASTRITIS 119 0.0045
230 LIMB DISCOMFORT 139 0.0045
231 PRODUCT PRESCRIBING ERROR 107 0.0045
232 INCORRECT DOSE ADMINISTERED 1021 0.0045
233 BURNING SENSATION 313 0.0045
234 MUSCULOSKELETAL STIFFNESS 391 0.0045
235 BLOOD PRESSURE SYSTOLIC INCREASED 87 0.0045
236 GASTROINTESTINAL PAIN 49 0.0044
237 FOOT OPERATION 22 0.0044
238 PERIPHERAL SWELLING 679 0.0044
239 MIGRAINE 420 0.0044
240 IMPAIRED DRIVING ABILITY 50 0.0044
241 MIDDLE INSOMNIA 82 0.0044
242 MOUTH HAEMORRHAGE 32 0.0044
243 RETCHING 93 0.0044
244 DRUG TOLERANCE 22 0.0043
245 CARDIAC FLUTTER 28 0.0043
246 PHARYNGOLARYNGEAL PAIN 23 0.0043
247 ARTHRALGIA 1797 0.0043
248 ARTHRITIS INFECTIVE 20 0.0043
249 BOWEL MOVEMENT IRREGULARITY 33 0.0043
250 HOT FLUSH 324 0.0043
251 SKIN WARM 25 0.0043
252 EAR DISCOMFORT 44 0.0043
253 INCREASED UPPER AIRWAY SECRETION 22 0.0043
254 SKIN TIGHTNESS 20 0.0042
255 HAIR DISORDER 35 0.0042
256 CONSTIPATION 926 0.0042
257 ATELECTASIS 41 0.0042
258 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 143 0.0042
259 BLADDER DISORDER 42 0.0042
260 DYSSTASIA 123 0.0042
261 GLOSSODYNIA 94 0.0042
262 FEELING ABNORMAL 1001 0.0042
263 JOINT SWELLING 504 0.0042
264 CHOKING SENSATION 23 0.0042
265 IRRITABLE BOWEL SYNDROME 89 0.0041
266 BLOOD IRON DECREASED 49 0.0041
267 PRODUCT USE IN UNAPPROVED INDICATION 1021 0.0041
268 SYNOVIAL CYST 19 0.0041
269 PAIN IN EXTREMITY 1212 0.0041
270 HAEMORRHOIDS 80 0.0041
271 TOOTH INFECTION 54 0.0041
272 HAEMORRHOIDAL HAEMORRHAGE 20 0.0041
273 SINUSITIS 419 0.0041
274 FACIAL PAIN 36 0.0040
275 SPINAL PAIN 47 0.0040
276 CHROMATURIA 90 0.0040
277 BALANCE DISORDER 344 0.0040
278 NO ADVERSE EVENT 721 0.0040
279 VITAMIN D DECREASED 34 0.0040
280 SCAR 68 0.0040
281 TENDON PAIN 30 0.0040
282 SOMNAMBULISM 26 0.0040
283 INSOMNIA 1054 0.0040
284 BURSITIS 48 0.0040
285 SKIN LACERATION 43 0.0040
286 FLUID RETENTION 201 0.0039
287 DERMATITIS CONTACT 45 0.0039
288 ANKLE FRACTURE 61 0.0039
289 RASH GENERALISED 102 0.0039
290 OSTEOPOROSIS 162 0.0039
291 FOOD POISONING 21 0.0039
292 PRODUCT ODOUR ABNORMAL 41 0.0039
293 IRON DEFICIENCY ANAEMIA 36 0.0039
294 LARGE INTESTINE POLYP 27 0.0039
295 FLATULENCE 221 0.0039
296 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 277 0.0039
297 UPPER-AIRWAY COUGH SYNDROME 32 0.0039
298 SCOLIOSIS 24 0.0039
299 BLOOD PRESSURE ABNORMAL 77 0.0039
300 LIMB INJURY 105 0.0039
301 CORONARY ARTERY OCCLUSION 53 0.0039
302 GRIP STRENGTH DECREASED 34 0.0039
303 KNEE OPERATION 38 0.0039
304 ODYNOPHAGIA 23 0.0038
305 HYPOAESTHESIA 575 0.0038
306 GASTROINTESTINAL SOUNDS ABNORMAL 19 0.0038
307 SOMNOLENCE 771 0.0038
308 BLISTER 215 0.0038
309 WEIGHT FLUCTUATION 40 0.0038
310 POLYP 25 0.0038
311 EPISTAXIS 284 0.0038
312 MADAROSIS 44 0.0038
313 DIZZINESS 1889 0.0038
314 NIGHT SWEATS 122 0.0038
315 HEAD DISCOMFORT 67 0.0038
316 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 269 0.0038
317 INFLUENZA LIKE ILLNESS 311 0.0038
318 GAIT DISTURBANCE 723 0.0038
319 ARTERIOSCLEROSIS CORONARY ARTERY 25 0.0038
320 ERUCTATION 73 0.0038
321 RENAL FAILURE CHRONIC 29 0.0038
322 SWELLING 352 0.0038
323 LOW DENSITY LIPOPROTEIN INCREASED 29 0.0037
324 CONCUSSION 29 0.0037
325 UPPER RESPIRATORY TRACT INFECTION 173 0.0037
326 FEELING HOT 229 0.0037
327 END STAGE RENAL DISEASE 68 0.0037
328 LACERATION 35 0.0037
329 DIZZINESS POSTURAL 36 0.0037
330 THERAPEUTIC RESPONSE SHORTENED 123 0.0037
331 KNEE ARTHROPLASTY 78 0.0037
332 UTERINE LEIOMYOMA 27 0.0037
333 VITAMIN D DEFICIENCY 36 0.0037
334 VARICOSE VEIN 19 0.0037
335 NODULE 48 0.0037
336 INFUSION SITE ERYTHEMA 31 0.0037
337 WRIST FRACTURE 44 0.0037
338 IMPAIRED WORK ABILITY 78 0.0036
339 BRONCHITIS 270 0.0036
340 DIARRHOEA HAEMORRHAGIC 34 0.0036
341 CHOLELITHIASIS 119 0.0036
342 GOUT 65 0.0036
343 APPETITE DISORDER 24 0.0036
344 DYSURIA 133 0.0036
345 GASTROENTERITIS VIRAL 65 0.0036
346 TOOTH DISORDER 80 0.0036
347 POLLAKIURIA 150 0.0036
348 ANAPHYLACTIC REACTION 198 0.0036
349 PAIN 2189 0.0036
350 HEPATIC STEATOSIS 66 0.0035
351 MUSCLE SPASMS 650 0.0035
352 DIVERTICULITIS 98 0.0035
353 RENAL FAILURE 469 0.0035
354 GALLBLADDER DISORDER 63 0.0035
355 HAND FRACTURE 25 0.0035
356 LIP DRY 32 0.0035
357 GINGIVITIS 19 0.0035
358 FEMUR FRACTURE 109 0.0035
359 HAIR TEXTURE ABNORMAL 47 0.0035
360 DRY MOUTH 285 0.0035
361 STOMATITIS 213 0.0035
362 ARTHROPOD BITE 26 0.0035
363 SCRATCH 37 0.0035
364 SCAB 40 0.0035
365 BLOOD COUNT ABNORMAL 53 0.0035
366 OSTEOPENIA 53 0.0035
367 ONYCHOCLASIS 24 0.0035
368 SUNBURN 26 0.0035
369 OEDEMA PERIPHERAL 423 0.0035
370 NERVOUSNESS 181 0.0035
371 UNEVALUABLE EVENT 262 0.0035
372 HAIR COLOUR CHANGES 43 0.0035
373 TENSION 21 0.0034
374 PAROSMIA 26 0.0034
375 SKIN DISCOLOURATION 158 0.0034
376 FAECES SOFT 25 0.0034
377 ACTIVITIES OF DAILY LIVING IMPAIRED 68 0.0034
378 PARAESTHESIA 540 0.0034
379 BLOOD CHOLESTEROL INCREASED 160 0.0034
380 FOOT DEFORMITY 38 0.0034
381 PRURITUS 1317 0.0034
382 PERIPHERAL COLDNESS 47 0.0034
383 AORTIC ANEURYSM 26 0.0034
384 CHOLECYSTECTOMY 39 0.0034
385 PROSTATIC SPECIFIC ANTIGEN INCREASED 47 0.0034
386 WRONG PRODUCT ADMINISTERED 23 0.0034
387 CONTRAINDICATED PRODUCT ADMINISTERED 103 0.0034
388 NEPHROLITHIASIS 156 0.0034
389 INCOHERENT 22 0.0034
390 DYSGEUSIA 252 0.0034
391 ANORECTAL DISCOMFORT 18 0.0034
392 EYE HAEMORRHAGE 45 0.0034
393 GINGIVAL BLEEDING 46 0.0034
394 EYE INFECTION 38 0.0034
395 HEART RATE IRREGULAR 76 0.0034
396 WRONG TECHNIQUE IN DRUG USAGE PROCESS 122 0.0034
397 FLUSHING 341 0.0034
398 CHOLECYSTITIS ACUTE 19 0.0033
399 HEADACHE 2095 0.0033
400 SLUGGISHNESS 34 0.0033
401 HAEMATOCRIT DECREASED 66 0.0033
402 CARDIAC VALVE DISEASE 19 0.0033
403 TONGUE DISORDER 24 0.0033
404 HEPATIC ENZYME INCREASED 226 0.0033
405 MUSCULOSKELETAL DISORDER 63 0.0033
406 HYPERHIDROSIS 426 0.0033
407 FORMICATION 23 0.0033
408 COORDINATION ABNORMAL 46 0.0033
409 ABNORMAL FAECES 27 0.0033
410 TEMPERATURE INTOLERANCE 34 0.0033
411 COLD SWEAT 58 0.0033
412 INJURY 231 0.0033
413 MOBILITY DECREASED 236 0.0033
414 BREAST MASS 22 0.0033
415 CENTRAL NERVOUS SYSTEM LESION 45 0.0033
416 URINARY INCONTINENCE 97 0.0033
417 PHARYNGEAL SWELLING 32 0.0033
418 FEELING COLD 90 0.0032
419 FALL 1074 0.0032
420 JOINT DISLOCATION 34 0.0032
421 NASAL CONGESTION 189 0.0032
422 PAIN IN JAW 91 0.0032
423 POST PROCEDURAL INFECTION 26 0.0032
424 EYE DISORDER 105 0.0032
425 BONE PAIN 187 0.0032
426 OROPHARYNGEAL PAIN 295 0.0032
427 DEPRESSION 722 0.0032
428 BLOOD PRESSURE FLUCTUATION 76 0.0032
429 PETECHIAE 33 0.0032
430 RHINORRHOEA 204 0.0032
431 RASH PRURITIC 171 0.0032
432 RESPIRATORY TRACT CONGESTION 50 0.0031
433 SKIN MASS 21 0.0031
434 ANXIETY 893 0.0031
435 EAR PAIN 61 0.0031
436 ATRIAL FLUTTER 25 0.0031
437 MYALGIA 532 0.0031
438 BLOOD DISORDER 25 0.0031
439 IMMUNE SYSTEM DISORDER 41 0.0031
440 ANKYLOSING SPONDYLITIS 41 0.0031
441 HAEMOGLOBIN ABNORMAL 20 0.0031
442 CEREBRAL DISORDER 23 0.0031
443 IMPAIRED HEALING 102 0.0031
444 FATIGUE 2413 0.0031
445 MUSCULAR WEAKNESS 351 0.0031
446 MUSCLE DISORDER 25 0.0031
447 RED BLOOD CELL COUNT DECREASED 88 0.0031
448 CHEST PAIN 570 0.0031
449 HERPES ZOSTER 176 0.0031
450 ECCHYMOSIS 21 0.0031
451 DRY THROAT 31 0.0030
452 AGEUSIA 76 0.0030
453 VISUAL FIELD DEFECT 22 0.0030
454 RHEUMATOID ARTHRITIS 345 0.0030
455 HYPERSOMNIA 87 0.0030
456 HAIR GROWTH ABNORMAL 21 0.0030
457 PSORIATIC ARTHROPATHY 123 0.0030
458 VISION BLURRED 416 0.0030
459 INCONTINENCE 32 0.0030
460 ORAL HERPES 59 0.0030
461 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 612 0.0030
462 ADVERSE REACTION 40 0.0030
463 RIB FRACTURE 62 0.0030
464 BLOOD MAGNESIUM DECREASED 26 0.0030
465 BREAST PAIN 32 0.0030
466 PALPITATIONS 351 0.0030
467 SPINAL FRACTURE 60 0.0030
468 PANIC ATTACK 109 0.0030
469 MULTIPLE SCLEROSIS 143 0.0030
470 RASH PAPULAR 67 0.0030
471 HEART RATE INCREASED 296 0.0030
472 NEUROPATHY PERIPHERAL 284 0.0030
473 FOOD ALLERGY 23 0.0030
474 MELAENA 65 0.0030
475 DYSPHAGIA 280 0.0029
476 TOOTH ABSCESS 30 0.0029
477 URINARY TRACT INFECTION 502 0.0029
478 ABDOMINAL DISTENSION 307 0.0029
479 OCULAR DISCOMFORT 33 0.0029
480 HEAD INJURY 93 0.0029
481 INFLAMMATION 151 0.0029
482 VERTIGO 178 0.0029
483 BLOOD TEST ABNORMAL 41 0.0029
484 PRODUCT CONTAINER ISSUE 25 0.0029
485 MITRAL VALVE INCOMPETENCE 33 0.0029
486 ABASIA 72 0.0029
487 FEEDING DISORDER 59 0.0029
488 QUALITY OF LIFE DECREASED 39 0.0029
489 TOOTH FRACTURE 32 0.0029
490 HYPERTENSION 614 0.0029
491 SNEEZING 65 0.0029
492 ABNORMAL DREAMS 80 0.0029
493 HERNIA 56 0.0029
494 RENAL CYST 23 0.0029
495 NAUSEA 2290 0.0029
496 CHILLS 339 0.0029
497 ANAL INCONTINENCE 26 0.0029
498 MEMORY IMPAIRMENT 397 0.0029
499 LACRIMATION INCREASED 87 0.0029
500 DRUG EFFECT DECREASED 155 0.0029
501 ANOREXIA 37 0.0029
502 MUSCLE TWITCHING 66 0.0029
503 MULTIPLE SCLEROSIS RELAPSE 196 0.0029
504 TASTE DISORDER 58 0.0029
505 DYSPHONIA 167 0.0029
506 RHINITIS 23 0.0028
507 BLOOD CALCIUM INCREASED 25 0.0028
508 VITREOUS FLOATERS 28 0.0028
509 APHTHOUS ULCER 22 0.0028
510 HOSPICE CARE 28 0.0028
511 SKIN HAEMORRHAGE 42 0.0028
512 EUPHORIC MOOD 29 0.0028
513 BLOOD POTASSIUM DECREASED 85 0.0028
514 BASAL CELL CARCINOMA 44 0.0028
515 WEIGHT DECREASED 787 0.0028
516 THERMAL BURN 20 0.0028
517 RASH 1228 0.0028
518 ANHEDONIA 74 0.0028
519 BEDRIDDEN 37 0.0028
520 GAIT INABILITY 94 0.0028
521 UPPER LIMB FRACTURE 56 0.0028
522 DIPLOPIA 73 0.0028
523 ABDOMINAL PAIN LOWER 71 0.0028
524 KIDNEY INFECTION 55 0.0028
525 ADRENAL INSUFFICIENCY 34 0.0028
526 SALIVARY HYPERSECRETION 28 0.0028
527 FOOT FRACTURE 53 0.0028
528 INFUSION SITE PAIN 36 0.0028
529 PRODUCT DOSE OMISSION IN ERROR 79 0.0028
530 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 134 0.0028
531 TRANSIENT ISCHAEMIC ATTACK 94 0.0028
532 DISTURBANCE IN ATTENTION 150 0.0028
533 ASTHENIA 1044 0.0028
534 CHOLECYSTITIS 33 0.0028
535 TRICUSPID VALVE INCOMPETENCE 22 0.0028
536 SKIN INFECTION 31 0.0028
537 LOSS OF CONSCIOUSNESS 354 0.0028
538 NEPHROPATHY TOXIC 31 0.0028
539 OBESITY 44 0.0028
540 DYSPNOEA EXERTIONAL 104 0.0028
541 RESPIRATION ABNORMAL 19 0.0028
542 BLOOD PRESSURE DECREASED 183 0.0028
543 MAJOR DEPRESSION 20 0.0027
544 ORAL DISORDER 20 0.0027
545 SKIN DISORDER 91 0.0027
546 SLEEP DISORDER 191 0.0027
547 EAR INFECTION 72 0.0027
548 NASOPHARYNGITIS 498 0.0027
549 COAGULOPATHY 45 0.0027
550 WRONG DRUG ADMINISTERED 24 0.0027
551 DECREASED ACTIVITY 29 0.0027
552 IMMUNODEFICIENCY 40 0.0027
553 BRAIN FOG 42 0.0027
554 ACCIDENT 32 0.0027
555 GASTROINTESTINAL DISORDER 240 0.0027
556 DRUG ADMINISTRATION ERROR 82 0.0027
557 CHEST DISCOMFORT 273 0.0027
558 ERYTHEMA 547 0.0027
559 PHARYNGITIS 33 0.0027
560 HAEMORRHAGE 278 0.0027
561 HEMIPARESIS 45 0.0027
562 HUNGER 37 0.0027
563 HEART RATE DECREASED 93 0.0026
564 IMPAIRED GASTRIC EMPTYING 36 0.0026
565 VOMITING 1237 0.0026
566 NAIL DISORDER 23 0.0026
567 BLINDNESS UNILATERAL 37 0.0026
568 DISCOMFORT 160 0.0026
569 PULMONARY MASS 39 0.0026
570 TREMOR 434 0.0026
571 CRYING 95 0.0026
572 LOCALISED INFECTION 63 0.0026
573 VENTRICULAR EXTRASYSTOLES 27 0.0026
574 DIARRHOEA 1678 0.0026
575 DISORIENTATION 103 0.0026
576 MENTAL IMPAIRMENT 63 0.0026
577 DEEP VEIN THROMBOSIS 168 0.0026
578 HIP FRACTURE 83 0.0026
579 BLOOD CALCIUM DECREASED 29 0.0026
580 MASS 36 0.0026
581 THIRST 46 0.0026
582 BLOOD PRESSURE DIASTOLIC DECREASED 19 0.0026
583 WEIGHT INCREASED 576 0.0026
584 WHEEZING 152 0.0026
585 INJECTION SITE DISCOLOURATION 32 0.0026
586 DEHYDRATION 341 0.0026
587 SKIN ULCER 66 0.0026
588 BLOOD TRIGLYCERIDES INCREASED 45 0.0025
589 HIP ARTHROPLASTY 39 0.0025
590 CANDIDA INFECTION 43 0.0025
591 ABDOMINAL PAIN 590 0.0025
592 RASH ERYTHEMATOUS 121 0.0025
593 THINKING ABNORMAL 47 0.0025
594 URINARY RETENTION 84 0.0025
595 URINE OUTPUT DECREASED 22 0.0025
596 HEREDITARY ANGIOEDEMA 27 0.0025
597 MACULAR DEGENERATION 30 0.0025
598 ALOPECIA 493 0.0025
599 CELLULITIS 126 0.0025
600 PHOTOPHOBIA 47 0.0025
601 NIGHTMARE 86 0.0025
602 DEPRESSED MOOD 131 0.0025
603 INTENTIONAL PRODUCT USE ISSUE 217 0.0025
604 PULMONARY THROMBOSIS 27 0.0025
605 FRUSTRATION TOLERANCE DECREASED 20 0.0025
606 HAEMOPTYSIS 69 0.0025
607 CATARACT 147 0.0025
608 AUTOIMMUNE DISORDER 24 0.0025
609 STAPHYLOCOCCAL INFECTION 81 0.0025
610 HALLUCINATION 185 0.0025
611 EYE PAIN 138 0.0024
612 DYSPNOEA 1384 0.0024
613 HAEMOGLOBIN DECREASED 251 0.0024
614 DENTAL CARIES 27 0.0024
615 BLINDNESS TRANSIENT 18 0.0024
616 ROAD TRAFFIC ACCIDENT 102 0.0024
617 BODY TEMPERATURE DECREASED 24 0.0024
618 VIRAL INFECTION 81 0.0024
619 PRESYNCOPE 59 0.0024
620 DYSARTHRIA 91 0.0024
621 ARTERIAL OCCLUSIVE DISEASE 19 0.0024
622 PROCEDURAL PAIN 67 0.0024
623 EYE DISCHARGE 25 0.0024
624 RENAL IMPAIRMENT 202 0.0024
625 LIVER INJURY 59 0.0024
626 OVARIAN CYST 24 0.0024
627 WHITE BLOOD CELL COUNT INCREASED 92 0.0024
628 LIVER DISORDER 106 0.0024
629 SURGERY 140 0.0024
630 OESOPHAGITIS 26 0.0024
631 MUSCLE ATROPHY 30 0.0024
632 SENSORY DISTURBANCE 38 0.0024
633 MUSCLE SPASTICITY 29 0.0024
634 PULMONARY CONGESTION 31 0.0023
635 MENORRHAGIA 46 0.0023
636 INFLUENZA 261 0.0023
637 FUNGAL INFECTION 78 0.0023
638 PAIN OF SKIN 63 0.0023
639 ARTERIOSCLEROSIS 22 0.0023
640 CYST 29 0.0023
641 HELICOBACTER INFECTION 24 0.0023
642 WHITE BLOOD CELL COUNT DECREASED 253 0.0023
643 SHOCK HAEMORRHAGIC 19 0.0023
644 DEAFNESS 61 0.0023
645 DECUBITUS ULCER 19 0.0023
646 COUGH 653 0.0023
647 MALAISE 1020 0.0023
648 SPINAL DISORDER 22 0.0023
649 EYELID OEDEMA 27 0.0023
650 MYOCARDIAL INFARCTION 405 0.0023
651 MOOD SWINGS 74 0.0023
652 LUNG INFECTION 36 0.0023
653 MULTIPLE FRACTURES 38 0.0023
654 THROMBOSIS 186 0.0023
655 OPTIC NEURITIS 21 0.0023
656 ECONOMIC PROBLEM 35 0.0023
657 ACUTE KIDNEY INJURY 353 0.0023
658 LIVER FUNCTION TEST ABNORMAL 67 0.0023
659 APHASIA 69 0.0023
660 CARDIOMEGALY 28 0.0023
661 DISABILITY 45 0.0023
662 AMNESIA 148 0.0023
663 SPINAL OPERATION 28 0.0023
664 LABORATORY TEST ABNORMAL 67 0.0023
665 COGNITIVE DISORDER 106 0.0023
666 RESPIRATORY TRACT INFECTION 59 0.0023
667 ADVERSE DRUG REACTION 203 0.0023
668 HAEMATURIA 77 0.0022
669 UTERINE PERFORATION 19 0.0022
670 COELIAC DISEASE 22 0.0022
671 RESTLESSNESS 82 0.0022
672 HEPATOMEGALY 22 0.0022
673 MOUTH ULCERATION 47 0.0022
674 DRY EYE 111 0.0022
675 INSURANCE ISSUE 34 0.0022
676 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 116 0.0022
677 POOR VENOUS ACCESS 23 0.0022
678 PRESCRIBED OVERDOSE 43 0.0022
679 PRODUCTIVE COUGH 106 0.0022
680 SPUTUM DISCOLOURED 21 0.0022
681 CORONARY ARTERY DISEASE 67 0.0022
682 PULMONARY EMBOLISM 210 0.0022
683 BLOOD UREA INCREASED 37 0.0022
684 EATING DISORDER 47 0.0022
685 THYROID DISORDER 34 0.0022
686 INCREASED APPETITE 42 0.0022
687 DECREASED APPETITE 510 0.0022
688 HYPOPHAGIA 56 0.0022
689 ANAEMIA 417 0.0022
690 THERAPEUTIC PRODUCT EFFECT DECREASED 97 0.0022
691 SKIN LESION 59 0.0021
692 ADVERSE EVENT 198 0.0021
693 PELVIC PAIN 39 0.0021
694 INFLAMMATORY BOWEL DISEASE 21 0.0021
695 PRODUCT DOSE OMISSION 140 0.0021
696 INJECTION SITE BRUISING 171 0.0021
697 TYPE 2 DIABETES MELLITUS 72 0.0021
698 INTESTINAL PERFORATION 24 0.0021
699 ACUTE MYOCARDIAL INFARCTION 63 0.0021
700 INJECTION SITE ERYTHEMA 265 0.0021
701 PSORIASIS 279 0.0021
702 POST PROCEDURAL COMPLICATION 41 0.0021
703 HYPOTHYROIDISM 68 0.0021
704 ANGER 72 0.0021
705 BLOOD SODIUM DECREASED 40 0.0021
706 OEDEMA 115 0.0021
707 FEAR 57 0.0021
708 SPEECH DISORDER 111 0.0021
709 DIALYSIS 30 0.0021
710 TENDON RUPTURE 26 0.0021
711 THERAPY CESSATION 108 0.0021
712 LETHARGY 121 0.0021
713 LYMPHOCYTE COUNT DECREASED 37 0.0021
714 SUPRAVENTRICULAR TACHYCARDIA 20 0.0021
715 SYNCOPE 209 0.0021
716 MOVEMENT DISORDER 67 0.0021
717 OCULAR HYPERAEMIA 99 0.0021
718 PULMONARY FIBROSIS 40 0.0021
719 LOWER LIMB FRACTURE 40 0.0021
720 FULL BLOOD COUNT ABNORMAL 22 0.0021
721 RED BLOOD CELL SEDIMENTATION RATE INCREASED 23 0.0021
722 UROSEPSIS 19 0.0021
723 PHOTOSENSITIVITY REACTION 34 0.0021
724 ILLNESS 212 0.0021
725 INCORRECT PRODUCT STORAGE 27 0.0021
726 EYE PRURITUS 69 0.0021
727 METRORRHAGIA 35 0.0021
728 DRUG DOSE OMISSION 339 0.0020
729 VAGINAL HAEMORRHAGE 89 0.0020
730 ORAL CANDIDIASIS 27 0.0020
731 IRRITABILITY 123 0.0020
732 SKIN CANCER 44 0.0020
733 BLOOD POTASSIUM INCREASED 33 0.0020
734 TUBULOINTERSTITIAL NEPHRITIS 38 0.0020
735 CEREBROVASCULAR ACCIDENT 342 0.0020
736 DRUG INTOLERANCE 194 0.0020
737 HYPOKINESIA 29 0.0020
738 SECRETION DISCHARGE 25 0.0020
739 CONDITION AGGRAVATED 602 0.0020
740 LYMPHADENOPATHY 70 0.0020
741 VISUAL IMPAIRMENT 245 0.0020
742 POST PROCEDURAL HAEMORRHAGE 23 0.0020
743 MOTOR DYSFUNCTION 20 0.0020
744 OXYGEN SATURATION DECREASED 110 0.0020
745 PARALYSIS 28 0.0020
746 ASTHMA 221 0.0020
747 ANGINA PECTORIS 56 0.0020
748 SMALL INTESTINAL OBSTRUCTION 24 0.0019
749 AGITATION 143 0.0019
750 SUICIDAL IDEATION 178 0.0019
751 GENERALISED OEDEMA 24 0.0019
752 RENAL TUBULAR NECROSIS 19 0.0019
753 APHONIA 27 0.0019
754 SKIN EXFOLIATION 163 0.0019
755 INJECTION SITE URTICARIA 47 0.0019
756 DERMATITIS ALLERGIC 24 0.0019
757 FOLLICULITIS 20 0.0019
758 WOUND 53 0.0019
759 INJECTION SITE RASH 58 0.0019
760 DEVICE USE ISSUE 33 0.0019
761 CONFUSIONAL STATE 303 0.0019
762 GLAUCOMA 36 0.0019
763 HYPERCALCAEMIA 23 0.0019
764 BODY TEMPERATURE INCREASED 38 0.0019
765 DRUG ERUPTION 33 0.0019
766 PEMPHIGUS 23 0.0018
767 PALLOR 50 0.0018
768 FULL BLOOD COUNT DECREASED 37 0.0018
769 HAND DEFORMITY 24 0.0018
770 PULMONARY HYPERTENSION 38 0.0018
771 DYSKINESIA 74 0.0018
772 MENTAL DISORDER 79 0.0018
773 IMPAIRED QUALITY OF LIFE 26 0.0018
774 DIABETES MELLITUS 137 0.0018
775 SKIN FISSURES 35 0.0018
776 INJECTION SITE REACTION 123 0.0018
777 PNEUMONIA 577 0.0018
778 ATAXIA 21 0.0018
779 MOOD ALTERED 48 0.0018
780 EMOTIONAL DISTRESS 213 0.0018
781 PHARYNGITIS STREPTOCOCCAL 19 0.0018
782 DEMENTIA 49 0.0018
783 VISUAL ACUITY REDUCED 58 0.0017
784 HYPOACUSIS 75 0.0017
785 CARDIAC DISORDER 163 0.0017
786 INJECTION SITE PRURITUS 116 0.0017
787 MENTAL STATUS CHANGES 48 0.0017
788 INFECTION 250 0.0017
789 INJECTION SITE NODULE 19 0.0017
790 UNDERDOSE 126 0.0017
791 PLEURAL EFFUSION 105 0.0017
792 BONE DENSITY DECREASED 54 0.0017
793 EMOTIONAL DISORDER 53 0.0017
794 LEUKOCYTOSIS 31 0.0017
795 GLOMERULAR FILTRATION RATE DECREASED 21 0.0017
796 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 29 0.0017
797 ATRIAL FIBRILLATION 166 0.0017
798 CLOSTRIDIUM DIFFICILE INFECTION 37 0.0017
799 ABSCESS 27 0.0017
800 CARDIOMYOPATHY 25 0.0017
801 SINUS TACHYCARDIA 24 0.0017
802 EYE IRRITATION 97 0.0017
803 PRODUCT SUBSTITUTION ISSUE 97 0.0017
804 DRY SKIN 224 0.0017
805 DERMATITIS 35 0.0017
806 THERAPY NON-RESPONDER 75 0.0017
807 BACTERIAL INFECTION 31 0.0017
808 GASTROENTERITIS 24 0.0016
809 CONVULSION 94 0.0016
810 PYREXIA 567 0.0016
811 INJECTION SITE SWELLING 125 0.0016
812 INFUSION RELATED REACTION 108 0.0016
813 PRODUCT QUALITY ISSUE 221 0.0016
814 HYPOTENSION 326 0.0016
815 PARANOIA 28 0.0016
816 INJECTION SITE MASS 60 0.0016
817 LYMPHOMA 25 0.0016
818 THERAPEUTIC RESPONSE DECREASED 98 0.0016
819 DELUSION 25 0.0016
820 CARDIAC FAILURE CONGESTIVE 129 0.0016
821 PRESCRIBED UNDERDOSE 32 0.0016
822 OFF LABEL USE 1404 0.0016
823 RENAL FAILURE ACUTE 68 0.0016
824 NERVOUS SYSTEM DISORDER 50 0.0016
825 HEPATIC CIRRHOSIS 30 0.0016
826 PLATELET COUNT DECREASED 170 0.0016
827 ANOSMIA 23 0.0016
828 METASTASES TO BONE 26 0.0016
829 BLOOD ALKALINE PHOSPHATASE INCREASED 39 0.0016
830 COVID-19 275 0.0016
831 INJECTION SITE INDURATION 20 0.0015
832 PLATELET COUNT INCREASED 20 0.0015
833 JAUNDICE 41 0.0015
834 FREQUENT BOWEL MOVEMENTS 41 0.0015
835 LOWER RESPIRATORY TRACT INFECTION 69 0.0015
836 HALLUCINATION, VISUAL 32 0.0015
837 INJECTION SITE PAIN 464 0.0015
838 LUNG DISORDER 74 0.0015
839 PSYCHOMOTOR HYPERACTIVITY 25 0.0015
840 ASPARTATE AMINOTRANSFERASE INCREASED 80 0.0015
841 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 271 0.0015
842 COLITIS 57 0.0015
843 PRODUCT DOSE OMISSION ISSUE 442 0.0015
844 MALIGNANT MELANOMA 20 0.0015
845 OSTEOMYELITIS 27 0.0015
846 SKIN REACTION 21 0.0015
847 HYPOXIA 52 0.0015
848 COLON CANCER 22 0.0015
849 HYPOKALAEMIA 68 0.0015
850 PERICARDIAL EFFUSION 34 0.0015
851 BONE LOSS 22 0.0015
852 INJECTION SITE WARMTH 30 0.0015
853 WITHDRAWAL SYNDROME 61 0.0015
854 BLOOD GLUCOSE INCREASED 268 0.0014
855 EJECTION FRACTION DECREASED 22 0.0014
856 RESPIRATORY DISORDER 42 0.0014
857 UVEITIS 19 0.0014
858 ALANINE AMINOTRANSFERASE INCREASED 86 0.0014
859 LIVER FUNCTION TEST INCREASED 30 0.0014
860 ACCIDENTAL OVERDOSE 51 0.0014
861 PHARMACEUTICAL PRODUCT COMPLAINT 36 0.0014
862 ECZEMA 72 0.0014
863 ILL-DEFINED DISORDER 83 0.0014
864 PULMONARY OEDEMA 61 0.0014
865 INTESTINAL OBSTRUCTION 51 0.0014
866 DISEASE PROGRESSION 159 0.0013
867 INTENTIONAL OVERDOSE 86 0.0013
868 CARDIOVASCULAR DISORDER 34 0.0013
869 ABNORMAL BEHAVIOUR 53 0.0013
870 ERECTILE DYSFUNCTION 34 0.0013
871 ORTHOSTATIC HYPOTENSION 23 0.0013
872 PRODUCT ADMINISTERED AT INAPPROPRIATE SITE 24 0.0013
873 GLYCOSYLATED HAEMOGLOBIN INCREASED 33 0.0013
874 STEVENS-JOHNSON SYNDROME 29 0.0013
875 INJECTION SITE HAEMORRHAGE 104 0.0013
876 CONJUNCTIVITIS 24 0.0013
877 ACNE 98 0.0013
878 BLOOD GLUCOSE DECREASED 62 0.0013
879 PNEUMONIA ASPIRATION 32 0.0013
880 SEIZURE 147 0.0013
881 APPLICATION SITE PAIN 28 0.0013
882 SYSTEMIC LUPUS ERYTHEMATOSUS 45 0.0013
883 HYPERGLYCAEMIA 46 0.0013
884 PNEUMOTHORAX 20 0.0013
885 HEPATIC FAILURE 38 0.0013
886 APPLICATION SITE ERYTHEMA 33 0.0013
887 TOOTH LOSS 26 0.0013
888 PANCREATITIS 66 0.0012
889 THERAPY INTERRUPTED 89 0.0012
890 TREATMENT NONCOMPLIANCE 68 0.0012
891 TACHYCARDIA 110 0.0012
892 SEPSIS 138 0.0012
893 APATHY 18 0.0012
894 PRODUCT AVAILABILITY ISSUE 28 0.0012
895 ANGIOEDEMA 54 0.0012
896 FRACTURE 23 0.0012
897 PNEUMONITIS 33 0.0012
898 BLOOD CREATININE INCREASED 79 0.0012
899 BLINDNESS 49 0.0012
900 SKIN BURNING SENSATION 85 0.0012
901 SHOCK 27 0.0012
902 CEREBRAL HAEMORRHAGE 42 0.0012
903 INTENTIONAL DOSE OMISSION 33 0.0012
904 LUNG NEOPLASM MALIGNANT 47 0.0011
905 BLOOD GLUCOSE ABNORMAL 21 0.0011
906 NEOPLASM PROGRESSION 39 0.0011
907 HAEMATOMA 29 0.0011
908 SKIN IRRITATION 51 0.0011
909 MALIGNANT NEOPLASM PROGRESSION 113 0.0011
910 OVERDOSE 236 0.0011
911 NEOPLASM MALIGNANT 73 0.0011
912 C-REACTIVE PROTEIN INCREASED 39 0.0011
913 ISCHAEMIC STROKE 19 0.0011
914 GENERAL PHYSICAL HEALTH DETERIORATION 123 0.0011
915 INTENTIONAL DRUG MISUSE 22 0.0011
916 PLASMA CELL MYELOMA 41 0.0010
917 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 24 0.0010
918 COLITIS ULCERATIVE 46 0.0010
919 SUICIDE ATTEMPT 62 0.0010
920 RESPIRATORY DISTRESS 28 0.0010
921 OSTEONECROSIS OF JAW 25 0.0010
922 PRODUCT ADHESION ISSUE 36 0.0010
923 UNRESPONSIVE TO STIMULI 26 0.0010
924 PROTEINURIA 19 0.0010
925 DEVICE MALFUNCTION 70 0.0010
926 SEDATION 26 0.0010
927 ACUTE RESPIRATORY FAILURE 19 0.0010
928 DEVICE ISSUE 88 0.0010
929 RESPIRATORY ARREST 27 0.0010
930 DRUG DEPENDENCE 155 0.0010
931 BLOOD BILIRUBIN INCREASED 26 0.0010
932 ASCITES 28 0.0010
933 ARRHYTHMIA 45 0.0009
934 DRUG INTERACTION 149 0.0009
935 APPLICATION SITE PRURITUS 21 0.0009
936 PSYCHOTIC DISORDER 27 0.0009
937 HYPERKALAEMIA 32 0.0009
938 NEUTROPHIL COUNT DECREASED 37 0.0009
939 DISEASE RECURRENCE 43 0.0009
940 DEPRESSED LEVEL OF CONSCIOUSNESS 35 0.0009
941 INTERNATIONAL NORMALISED RATIO INCREASED 25 0.0009
942 ENCEPHALOPATHY 21 0.0009
943 SEPTIC SHOCK 37 0.0008
944 PANCREATITIS ACUTE 19 0.0008
945 FEBRILE NEUTROPENIA 56 0.0008
946 DERMATITIS ATOPIC 44 0.0008
947 HOSPITALISATION 127 0.0008
948 RESPIRATORY FAILURE 60 0.0008
949 HEPATITIS 21 0.0008
950 DELIRIUM 28 0.0008
951 ACCIDENTAL EXPOSURE TO PRODUCT 83 0.0008
952 MUCOSAL INFLAMMATION 21 0.0008
953 NEEDLE ISSUE 23 0.0008
954 EXPOSURE VIA SKIN CONTACT 20 0.0008
955 DRUG EXPOSURE DURING PREGNANCY 26 0.0008
956 AGGRESSION 38 0.0008
957 GASTRIC CANCER 19 0.0007
958 MENSTRUATION IRREGULAR 20 0.0007
959 HYPONATRAEMIA 42 0.0007
960 THROMBOCYTOPENIA 82 0.0007
961 PANCYTOPENIA 40 0.0007
962 TREATMENT FAILURE 58 0.0007
963 DEVICE DISLOCATION 30 0.0007
964 METABOLIC ACIDOSIS 22 0.0007
965 BREAST CANCER 62 0.0007
966 EPILEPSY 19 0.0006
967 MATERNAL EXPOSURE DURING PREGNANCY 55 0.0006
968 DRUG WITHDRAWAL SYNDROME 54 0.0006
969 LEUKOPENIA 30 0.0006
970 PROSTATE CANCER 47 0.0006
971 CARDIAC ARREST 48 0.0006
972 OSTEONECROSIS 19 0.0006
973 HYPOGLYCAEMIA 28 0.0006
974 DEATH 495 0.0006
975 ABORTION SPONTANEOUS 23 0.0006
976 ELECTROCARDIOGRAM QT PROLONGED 20 0.0006
977 NEUTROPENIA 75 0.0006
978 CARDIAC FAILURE 44 0.0005
979 EXPOSURE DURING PREGNANCY 34 0.0005
980 BRADYCARDIA 29 0.0005
981 COMA 26 0.0005
982 DEVICE BREAKAGE 22 0.0005
983 PRODUCT STORAGE ERROR 42 0.0005
984 CARDIO-RESPIRATORY ARREST 20 0.0005
985 INTERSTITIAL LUNG DISEASE 23 0.0005
986 DEVICE LEAKAGE 19 0.0004
987 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 20 0.0004
988 DEVICE DIFFICULT TO USE 28 0.0004
989 BLADDER CANCER 23 0.0004
990 DRUG ABUSE 24 0.0003
991 TOXICITY TO VARIOUS AGENTS 36 0.0002